Učitavanje...
Hypokalemia associated with mifepristone use in the treatment of Cushing’s syndrome
SUMMARY: Mifepristone is a promising option for the management of hypercortisolism associated with hyperglycemia. However, its use may result in serious electrolyte imbalances, especially during dose escalation. In our patient with adrenocorticotropic hormone-independent macro-nodular adrenal hyperp...
Spremljeno u:
| Izdano u: | Endocrinol Diabetes Metab Case Rep |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Bioscientifica Ltd
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6865352/ https://ncbi.nlm.nih.gov/pubmed/31743097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-19-0064 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|